Progressive acute kidney injury following myocardial infarction: cholesterol embolisation
- PMID: 21686929
- PMCID: PMC3028520
- DOI: 10.1136/bcr.06.2008.0103
Progressive acute kidney injury following myocardial infarction: cholesterol embolisation
Abstract
Acute kidney injury following acute coronary event can occur from multiple factors, including secondary to volume depletion, poor perfusion because of cardiac dysfunction, secondary to medications such as angiotensin converting enzyme inhibitors or angiotensin receptor blockers or because of aggressive diuretics or use of contrast agents. Atheroembolism (cholesterol embolisation) often occurs following an intervention, such as angiography or revascularisation procedure. An uncommon presentation of atheroembolic renal disease that likely was precipitated by the use of thrombolytics and/or anticoagulation is discussed.
Figures
Similar articles
-
Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.Am Heart J. 2015 Jul;170(1):110-6. doi: 10.1016/j.ahj.2015.04.019. Epub 2015 Apr 18. Am Heart J. 2015. PMID: 26093871 Clinical Trial.
-
Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study.BMJ. 2013 Jan 8;346:e8525. doi: 10.1136/bmj.e8525. BMJ. 2013. PMID: 23299844 Free PMC article.
-
Angiotensin-Converting Enzyme Inhibitors and Contrast-Associated Acute Kidney Injury After Coronary Angiography and Intervention.Am J Cardiovasc Drugs. 2021 Sep;21(5):487-497. doi: 10.1007/s40256-020-00455-5. Epub 2020 Dec 28. Am J Cardiovasc Drugs. 2021. PMID: 33369717 Review.
-
Atheroembolic renal disease.Lancet. 2010 May 8;375(9726):1650-60. doi: 10.1016/S0140-6736(09)62073-0. Epub 2010 Apr 8. Lancet. 2010. PMID: 20381857 Review.
-
Impact of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Renal Function in Chronic Kidney Disease Patients Undergoing Coronary Angiography.Cureus. 2021 Jan 20;13(1):e12808. doi: 10.7759/cureus.12808. Cureus. 2021. PMID: 33628676 Free PMC article.
References
-
- Modi KS, Rao VK. Atheroembolic renal disease. J Am Soc Nephrol 2001; 12: 1871–87 - PubMed
-
- Fukumoto Y, Tsutsui H, Tsuchihashi M, et al. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol 2003; 42: 211–6 - PubMed
-
- Blakenship JC, Butler M, Garbes A. prospective assessment of cholesterol embolization in patients with acute myocardial infarction treated with thrombolytic vs conservative therapy. Chest 1995; 107: 662–8 - PubMed
-
- Moolenaar W, Lamers CB. Cholesterol crystal embolization in the Netherlands. Arch Intern Med 1996; 156: 653–7 - PubMed
LinkOut - more resources
Full Text Sources